Generic store brand groceries can increasingly be found in the pantries, fridges, and freezers of Americans across all income groups. Once designed to communicate value and affordability, a new ...
New SEC rules could reshape the crypto ETF landscape by speeding up approvals, reducing the shutdown backlog and giving issuers a clearer and faster path to market. The SEC introduced new ...
The motion comes as class action attorneys are grappling with the advent of third parties that, through the use of technology, have advertised their services to assist potential class members in ...
Seventeen elements of the periodic table have taken on outsize importance because of their use in smartphones, electric vehicles, medical devices, and other technologies. They’re valued for their ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...
Like it or not, we all experience change. Rachel Gilbertson of The Art of Presence uses a framework called the Mountain 10 Journey to help people navigate. She said there are four elements to the ...
The U.S. Securities and Exchange Commission (SEC) on Wednesday approved a set of rules for exchanges to list exchange-traded products (ETPs) holding spot commodities, including cryptocurrencies, ...
US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...
I am a connoisseur of retro horror. I’ve been chasing the dragon since I first saw Halloween decades ago. My fondness for the great babysitter-in-peril pictures of years past makes me the target ...
Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...